|
|
|
Analysts'
Recommendation: | Buy | | 30 Days Ago: | Buy |
| | Analysts' Target: | $17 | | Analysts' Targets | | Jefferies & Co. | $17 | | Buy | | Friday, March 07, 2008 | TomoTherapy Incorporated develops, markets, and sells the Hi Art system, a radiation therapy system for the treatment of various types of cancers. The Hi Art system combines integrated CT imaging with radiation therapy to deliver radiation treatment while reducing radiation exposure to surrounding healthy tissue. The Hi Art system contains a linear accelerator, a device that generates external beam radiation that is used both to capture images and to deliver therapeutic radiation to selected targets in a helical, or spiral, delivery pattern 360 degrees around the body. It markets the Hi Art system to university research centers, community hospitals, private and governmental institutions, and cancer care centers in North America, Europe, the Middle East, and the Asia-Pacific, through direct sales personnel, sales agents, and distributors. The company was founded in 1997 and is headquartered in Madison, Wisconsin.
|
TOMO:
This call was made
on 06/29/08
@ $8.45
| Rating: |
$8.45 (06/29/08)
|
| Gain/Loss: |
-59.41%
in
498 days
|
| Target: |
$17.00
(+101.18%)
in > one year
|
|
